PDL BioPharma, Inc. (PDLI) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
59 DAMONTE RANCH PARKWAY RENO, NV 89521 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 8/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 193,451 | 394,590 | 532,114 | 242,141 | 220,352 | 293,687 | |||
| Cash and cash equivalents | 193,451 | 394,590 | 527,266 | 147,154 | 218,883 | 291,377 | |||
| Short-term investments | 4,848 | 94,987 | 1,469 | 2,310 | |||||
| Receivables | 66,135 | 84,690 | 84,796 | 151,302 | 58,398 | 57,897 | |||
| Inventory, net of allowances, customer advances and progress billings | 39,773 | 18,942 | 9,147 | 2,884 | |||||
| Inventory | 39,773 | 18,942 | 9,147 | 2,884 | |||||
| Derivative instruments and hedges, assets | 2,802 | 3,352 | |||||||
| Deferred tax assets | ✕ | ✕ | 981 | 375 | |||||
| Other undisclosed current assets | 14,536 | 18,995 | 14,386 | 1,704 | 177 | 586 | |||
| Total current assets: | 313,895 | 517,217 | 640,443 | 398,031 | 282,710 | 355,897 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 5,520 | 7,387 | 7,222 | 38 | 31 | 62 | |||
| Long-term investments and receivables | 827 | 771 | 93,524 | 234,768 | 306,507 | 305,615 | |||
| Long-term investments | 75,000 | 75,000 | |||||||
| Accounts and financing receivable, after allowance for credit loss | 827 | 771 | 18,524 | 159,768 | 306,507 | 305,615 | |||
| Intangible assets, net (including goodwill) | 23,298 | 51,319 | 215,823 | 228,542 | |||||
| Intangible assets, net (excluding goodwill) | 23,298 | 51,319 | 215,823 | 228,542 | |||||
| Derivative instruments and hedges | 717 | ||||||||
| Other noncurrent assets | 24,116 | 8,993 | 10,856 | 7,433 | 11,554 | 7,733 | |||
| Other undisclosed noncurrent assets | 348,463 | 378,049 | 275,255 | 346,575 | 415,376 | 292,326 | |||
| Total noncurrent assets: | 402,224 | 446,519 | 602,680 | 817,356 | 733,468 | 606,453 | |||
| TOTAL ASSETS: | 716,119 | 963,736 | 1,243,123 | 1,215,387 | 1,016,178 | 962,350 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 45,693 | 52,470 | 67,043 | 42,314 | 11,775 | 20,119 | |||
| Interest and dividends payable | 6,300 | ||||||||
| Taxes payable | 17 | 16 | 1,377 | 4,723 | 3,372 | 3,293 | |||
| Employee-related liabilities | 1,332 | ||||||||
| Accounts payable | 17,370 | 13,142 | 19,785 | 7,016 | 394 | 318 | |||
| Accrued liabilities | 28,306 | 39,312 | 45,881 | 30,575 | 8,009 | 8,876 | |||
| Debt | 126,066 | 24,966 | 175,496 | ||||||
| Other undisclosed current liabilities | 88,001 | (7,632) | |||||||
| Total current liabilities: | 45,693 | 52,470 | 193,109 | 130,315 | 36,741 | 187,983 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 27,250 | 124,644 | 117,415 | 232,443 | 232,835 | 276,228 | |||
| Long-term debt, excluding current maturities | 27,250 | 124,644 | 117,415 | 232,443 | 232,835 | 276,228 | |||
| Liabilities, other than long-term debt | 49,898 | 56,843 | 86,709 | 97,206 | 50,650 | 75,336 | |||
| Accounts payable and accrued liabilities | 10,700 | ||||||||
| Deferred compensation liability, classified | 578 | ||||||||
| Liability for uncertainty in income taxes | 26,356 | ||||||||
| Other liabilities | 49,898 | 56,843 | 44,709 | 54,556 | 50,650 | 37,702 | |||
| Business combination, contingent consideration, liability | 42,000 | 42,650 | |||||||
| Other undisclosed noncurrent liabilities | (37,634) | ||||||||
| Total noncurrent liabilities: | 77,148 | 181,487 | 204,124 | 329,649 | 283,485 | 313,930 | |||
| Total liabilities: | 122,841 | 233,957 | 397,233 | 459,964 | 320,226 | 501,913 | |||
| Equity | |||||||||
| Equity, attributable to parent | 593,200 | 729,779 | 845,890 | 751,143 | 695,952 | 460,437 | |||
| Common stock | 1,243 | 1,365 | 1,538 | 1,655 | 1,643 | 1,622 | |||
| Treasury stock, value | (2,103) | ||||||||
| Additional paid in capital | (78,875) | (98,030) | (102,443) | (107,628) | (117,983) | (119,874) | |||
| Accumulated other comprehensive income | 1,181 | 2,256 | 2,949 | ||||||
| Retained earnings | 670,832 | 828,547 | 945,614 | 857,116 | 810,036 | 575,740 | |||
| Equity, attributable to noncontrolling interest | 78 | 4,280 | |||||||
| Other undisclosed equity | |||||||||
| Total equity: | 593,278 | 729,779 | 845,890 | 755,423 | 695,952 | 460,437 | |||
| TOTAL LIABILITIES AND EQUITY: | 716,119 | 963,736 | 1,243,123 | 1,215,387 | 1,016,178 | 962,350 | |||
Income Statement (P&L) ($ in thousands)
| 8/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 54,757 | 198,110 | 320,060 | 244,301 | 590,448 | 581,225 | ||
| Revenue, net | ✕ | ✕ | ✕ | 103,574 | 31,543 | 723 | 575 | |
| Cost of revenue | (53,619) | (48,460) | (30,537) | (4,065) | ||||
| Cost of goods and services sold | (6,006) | (14,628) | (26,701) | (12,370) | ||||
| Gross profit: | 1,138 | 149,650 | 289,523 | 240,236 | 590,448 | 581,225 | ||
| Operating expenses | (154,571) | (248,704) | (126,280) | (114,899) | (40,069) | (34,914) | ||
| Other undisclosed operating income | 53,619 | 48,460 | 30,537 | 4,065 | ||||
| Operating income (loss): | (99,814) | (50,594) | 193,780 | 129,402 | 550,379 | 546,311 | ||
| Nonoperating income (expense) | 26,074 | (5,328) | (9,253) | (20,032) | (20,241) | (45,039) | ||
| Investment income, nonoperating | 6,030 | 6,829 | 10,968 | 588 | 368 | 315 | ||
| Interest and debt expense | (8,430) | (12,157) | (20,221) | (2,353) | 6,450 | (45,354) | ||
| Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | 8,430 | 12,157 | 20,221 | 2,353 | (6,450) | 45,354 | ||
| Income (loss) from continuing operations before income taxes: | (73,740) | (55,922) | 184,527 | 109,370 | 530,138 | 501,272 | ||
| Income tax expense (benefit) | 3,049 | (12,937) | (73,826) | (45,711) | (197,343) | (179,028) | ||
| Income (loss) from continuing operations: | (70,691) | (68,859) | 110,701 | 63,659 | 332,795 | 322,244 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | (70,691) | (68,859) | 110,701 | 63,659 | 332,795 | 322,244 | |
| Net income (loss): | (70,691) | (68,859) | 110,701 | 63,659 | 332,795 | 322,244 | ||
| Other undisclosed net income (loss) attributable to parent | 280 | 47 | (53) | |||||
| Net income (loss) available to common stockholders, diluted: | (70,411) | (68,859) | 110,748 | 63,606 | 332,795 | 322,244 | ||
Comprehensive Income ($ in thousands)
| 8/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (70,691) | (68,859) | 110,701 | 63,659 | 332,795 | 322,244 | ||
| Other comprehensive income (loss) | (1,181) | 1,181 | (2,256) | (693) | 7,837 | |||
| Comprehensive income (loss): | (70,691) | (70,040) | 111,882 | 61,403 | 332,102 | 330,081 | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 280 | 47 | (53) | |||||
| Comprehensive income (loss), net of tax, attributable to parent: | (70,411) | (70,040) | 111,929 | 61,350 | 332,102 | 330,081 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.